Patent Analysis

Sale

Non-Invasive Glucose Monitoring Patent Landscape

Global Non-Invasive Glucose Monitoring Patent Landscape Analysis 2024: By Product Type: Measuring Device, Transmitter and Software; By Sit Outlook: Arm/Wrist, Ear Lobe, Forefinger, Thumb and Others; By Application; Key Player Profiles

Global Non-Invasive Glucose Monitoring Market Size

The non-invasive glucose monitoring market was valued at USD 182.12 million in 2023. It is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032 and attain a market value of USD 373.26 million in 2032. The market value is impacted by the increasing use of such platforms and ongoing technological advancements in this field. There has been a significant increase in a number of patent applications associated with non-invasive glucose monitoring, driven by the increasing incidence of diabetes worldwide, leading to an increased demand for non-invasive glucose control solutions.

 

Patent Landscape Report Coverage

The Global Non-Invasive Glucose Monitoring Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for non-invasive glucose monitoring includes a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within non-invasive glucose monitoring technologies.

 

Spectrometry is a powerful technique used to integrate non-invasive glucose monitoring with other platforms that can provide additional information. This can combine the strengths of different sequencing methods for more comprehensive genome analysis. Therefore, such technical innovations have a significant impact on the patent landscape.

 

Global Non-Invasive Glucose Monitoring Patent Outlook

  • Increased innovations in optical, thermal, and spectroscopic technologies have improved the accuracy and reliability of non-invasive glucose monitoring devices. The application of new technologies in devices can lead to an increase in the number of patent applications in the coming years.
  • Continuous inventions and innovations for improvements in non-invasive glucose monitoring technology are driven due to its advantages like reduced discomfort compared to traditional fingertip methods, which improves patient compliance.
  • Non-invasive glucose monitoring is increasingly used with the growing elderly population base which is prone to diabetes. The utilization of these convenient monitoring solutions is driving the market demand and expanding the scope of this market.

 

What is Non-Invasive Glucose Monitoring?

Non-invasive glucose monitoring refers to methods and techniques that allow measuring blood sugar without piercing the skin (as with traditional fingertip methods). These methods typically use optical, thermal, electromagnetic, or other spectroscopic principles to estimate glucose levels through the skin or other body fluids. Non-invasive blood glucose monitoring aims to provide diabetics with convenient, painless, and continuous monitoring options that improve adherence to glucose monitoring programs and overall diabetes management.

 

Non-invasive glucose monitoring market continues to evolve, driven by the non-invasive devices integrated with wearable technology providing continuous monitoring and real-time information and improving management results. Also, support and funding policies by government and regulatory bodies for diabetes treatment and technologies is a driving factor to boost market value in the forecast period.

 

Non-Invasive Glucose Monitoring Industry Growth Drivers

Increasing Technological Advancements in Optical Sensing of Non-Invasive Glucose Monitoring is Expected to Augment the Market Growth

Advances in optical sensor technology for noninvasive glucose monitoring include innovations such as miniature sensors that use light to measure glucose levels through the interstitial fluid of the skin, improving patient outcomes and fueling market growth.

 

For instance, in 2023, Abbott announced that the U.S. FDA had cleared the application for its insulin delivery product “FreeStyle Libre 2” and “FreeStyle Libre 3”. This is an integrated continuous glucose monitoring (iCGM) sensor for integration into automated insulin delivery systems (AIDs). Abbott modified the sensors to allow integration with AID systems. Continuous development in devices is expected to boost the number of patent applications as companies involved in manufacturing wish to secure their intellectual property rights.

 

Integration of Machine Learning and Artificial Intelligence (AI) is Expected to Propel the Non-Invasive Glucose Monitoring Industry Growth

The integration of artificial intelligence and machine learning into non-invasive glucose monitoring systems improves data analysis capabilities, leading to enhanced accuracy and predictive power of glucose measurements. Companies are using artificial intelligence algorithms to interpret continuous glucose measurement data in real-time, providing users with personalized insights and alerts to better manage their diabetes by predicting trends and potential hypoglycemic or hyperglycemic events. The utilization of new technologies is likely to increase patent applications in the coming years.

 

Non-Invasive Glucose Monitoring Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation -

 

Breakup by Product Type

  • Measuring Device
  • Transmitter
  • Software

 

Breakup by Sit Outlook

  • Arm/Wrist
  • Ear Lobe
  • Forefinger
  • Thumb
  • Others

 

Breakup by Application

  • Intensive Insulin Therapy
  • Hypoglycemia
  • Diabetic Foot Ulcer Tracking
  • Others

 

Non-Invasive Glucose Monitoring Patent Segmentation Analysis

The breakup based on product type includes measuring devices, transmitters, and software. Spectrometer technology involves analysis by the absorption, emission or scattering of light to indirectly measure glucose levels in body tissues or fluids. This approach includes Raman spectroscopy, infrared spectroscopy, or other spectroscopic techniques to quantify glucose levels without invasive methods. It has become a promising option for continuous monitoring and better diabetes management.

 

The detailed technological data will be provided for all specified segments classified in this report.

 

Non-Invasive Glucose Monitoring Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for non-invasive glucose monitoring patents, having around 94,500 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

 

China is another significant jurisdiction. It has a substantial portion of the global geriatric population is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications. Innovations like the development of other novel diagnostic methods is amongst the major growth factors.

 

Patent Profile of Key Companies

Among the players with non-invasive glucose monitoring patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field.  Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

 

Dexcom Inc.

This California-based company specializes in continuous glucose monitoring (CGM) systems. Although Dexcom's current offering is invasive (requiring a sensor to be implanted under the skin), it is actively developing non-invasive CGM technologies to improve ease of use and convenience in diabetes management. The goal is to provide accurate glucose monitoring solutions without repetitive fingertips.

 

Abbott Laboratories

A global healthcare company headquartered in Illinois is known for its innovative medical devices and diagnostics. Abbott revolutionized glucose monitoring with the FreeStyle Libre system, a CGM device that continuously measures glucose levels with a sensor on the skin, eliminating the need for conventional fingertips. Abbott continues to develop non-invasive glucose monitoring technologies to improve diabetes care and quality of life for patients worldwide.

 

Other companies include Genentech INC, Human Genome Sciences INC, and Novartis AG, among others.

 

Reasons to Purchase this Report

The Global Non-Invasive Glucose Monitoring Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

 

  • Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators also makes it understandable which companies have important patents in this field of Non-Invasive Glucose Monitoring.
  • Innovation Insights: The patent analysis reveals new innovations and technologies in Non-Invasive Glucose Monitoring industry.
  • Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.
  • Risk Assessment: In technology-intensive fields such as pumps for microfluidic devices, risks of IP infringement are common. Analysing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.
  • Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

 

Scope of the Report Details
Analysis by Product Type 
  • Measuring Device 
  • Transmitter 
  • Software
Analysis by Sit Outlook
  • Arm/Wrist 
  • Ear Lobe 
  • Forefinger 
  • Thumb 
  • Others 
Analysis by Application
  • Intensive Insulin Therapy 
  • Hypoglycemia 
  • Diabetic Foot Ulcer Tracking 
  • Others
Key Players Mentioned 
  • Dexcom Inc.
  • Abbott Laboratories 
  • Genentech INC
  • Human Genome Sciences INC
  • Novartis AG
  • Others
Geographies Covered
  • North America 
  • Europe 
  • Asia Pacific
  • Others

 

Key Questions Answered in the Global Non-Invasive Glucose Monitoring Patent Landscape Report

  • Who are the key players in the non-invasive glucose monitoring patent landscape?
  • How is the patent portfolio distributed geographically?
  • What are the emerging trends in non-invasive glucose monitoring patents?
  • How has the patent landscape evolved over time?
  • What are the strategic insights for market players and investors?
  • What is the technological focus of patents in the non-invasive glucose monitoring industry?
  • How do patent strategies impact the competitive landscape?
  • What are the implications of patent filings in non-invasive glucose monitoring?
  • What are the challenges and opportunities in the non-invasive glucose monitoring patent landscape?
  • What are the regulatory and legal considerations?
  • What technological innovations have recently emerged in non-invasive glucose monitoring?

 

Related Reports

Global Blood Glucose Meters Market

Global Glucose Monitoring Devices Market

Global Blood Glucose Test Strip Market

Global Glucose Market

North America Continuous Glucose Monitoring Market

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Introduction
2    Executive Summary
3    Global Non-Invasive Glucose Monitoring Market Overview 

    3.1    Global Non-Invasive Glucose Monitoring Market Historical Value (2017-2023) 
    3.2    Global Non-Invasive Glucose Monitoring Market Forecast Value (2024-2032)
4    Global Non-Invasive  Glucose Monitoring Market Segmentation 
    4.1    Global Non-Invasive Glucose Monitoring Market Share by Product Type
        4.1.1    Market Overview
        4.1.2    Self-Monitoring Blood Glucose
            4.1.2.1    Glucometer Devices
            4.1.2.2    Test Strips
            4.1.2.3    Lancets
        4.1.3    Continuous Glucose Monitoring
            4.1.3.1    Sensors
            4.1.3.2    Durables
    4.2    Global Non-Invasive Glucose Monitoring Market Share by Site Outlook
        4.2.1    Market Overview
        4.2.2    Arm/Wrist
        4.2.3    Ear Lobe
        4.2.4    Forefinger
        4.2.5    Thumb
        4.2.6    Others
    4.3    Global Non-Invasive Glucose Monitoring Market Share by Application
        4.3.1    Market Overview
        4.3.2    Intensive Insulin Therapy
        4.3.3    Hypoglycemia
        4.3.4    Diabetic Foot Ulcer Tracking
        4.3.5    Others
    4.4    Global Non-Invasive Glucose Monitoring Market Share by End User
        4.4.1    Market Overview
        4.4.2    Home Healthcare Setting
        4.4.3    Healthcare Provider
        4.4.4    Research Institutes
        4.4.5    Others
5    Global Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    Porter’s Five Forces Analysis
    5.3    PESTEL Analysis 
    5.4    Industry Events, Initiatives, and Trends  
    5.5    Value Chain Analysis
6    Global Non-Invasive Glucose Monitoring Patent Landscape Analysis
    6.1    Patent Distribution by Publication Year
    6.2    Patent Distribution by Application Year
    6.3    Patent Distribution by Priority Year
    6.4    Analysis by Type of Patent
        6.4.1    Granted Patents 
        6.4.2    Patent Application
        6.4.3    Amended Application
        6.4.4    Search Report
    6.5    Analysis by Legal Status
        6.5.1    Active 
        6.5.2    Pending 
        6.5.3    Expired/Discontinued 
    6.6    Analysis by Patent Jurisdiction
    6.7    Analysis by Patent Age
    6.8    Analysis by Cooperative Patent Classification (CPC) Codes
    6.9    Average Time to Publish a Patent
        6.9.1    By Entities
        6.9.2    By Jurisdiction
        6.9.3    By Technology
    6.10    Analysis by Type of Entity (Academic and Non-Academic)
    6.11    Analysis by Top Applicants
    6.12    Analysis by Top Inventors
7    Global Non-Invasive Glucose Monitoring for Diagnostic Applications Patent Analysis by Technology
    7.1    Total Patents by Top Technologies 
    7.2    Time Evolution of Patents by Technology
    7.3    Emerging Technologies
    7.4    Patent Segmentation, By Product Type
        7.4.1    Time Evolution by Number of Patents
        7.4.2    Time Evolution by Number of Patent Families
        7.4.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.4.4    Analysis by Top Applicants
        7.4.5    Analysis by Top Inventors
    7.5    Patent Segmentation, By Site Outlook
*Complete technology list will be provided in the report.
8    EMR Patent Valuation Analysis
    8.1    Assessment Methodology
    8.2    High Value Patents
    8.3    Medium Value Patents
    8.4    Low Value Patents
9    Global Non-Invasive Glucose Monitoring for Diagnostic Applications – Top 10 Players Patent Analysis 
    9.1    Top 10 Entities by Number of Patents
    9.2    Analysis by Publication Year
    9.3    Analysis by Application Year
    9.4    Analysis by Priority Year
    9.5    Analysis by Type of Patent
    9.6    Analysis by Jurisdiction
    9.7    Analysis by Cooperative Patent Classification (CPC) Codes
    9.8    Analysis by Source of Innovation 
    9.9    Analysis by Forward and Backward Citations
    9.10    Analysis by Legal Status
    9.11    Analysis by Patent Age
    9.12    Analysis by Key Inventors
    9.13    Entity Dynamics
        9.13.1    Analysis by Type of Player (Academic vs Non-Academic)
        9.13.2    Analysis by Collaboration 
        9.13.3    Analysis by Technology
        9.13.4    Newcomers 
            9.13.4.1    Start-up Companies
            9.13.4.2    Established Companies
10    Patent Profile of Key Players
    10.1    Abbott Laboratories 
        10.1.1    Product Portfolio
        10.1.2    Patent Portfolio by Patent Families
        10.1.3    Time Evolution of Patents
        10.1.4    Geographical Patent Coverage 
        10.1.5    Patent Analysis by Technology
        10.1.6    Patent News and Developments
        10.1.7    Financial Analysis
        10.1.8    SWOT Analysis
    10.2    Dexcom Inc .    
    10.3    Genentech Inc .
    10.4    Human Genome Sciences Inc .
    10.5    Novartis AG 
11    Future Trends
12    Global Non-Invasive Glucose Monitoring Landscape (Additional Insight)* 

    12.1    Global Non-Invasive Glucose Monitoring: Developers Landscape
        12.1.1    Analysis by Year of Establishment
        12.1.2    Analysis by Company Size
        12.1.3    Analysis by Region
    12.2    Global Non-Invasive Glucose Monitoring: Product Landscape 
        12.2.1    Analysis by Product Type
        12.2.2    Analysis by Site Outlook
        12.2.3    Analysis by Application

 

*Additional insights are not provided in the standard report.

Purchase Full Report

Mini Report

$ 2639     $2399
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 4399     $3999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 5829     $5299
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 6929     $6299
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER